Related Experiment Videos
[Liver transplantation in tumors]
1Chirurgische Universitätsklinik Hamburg-Eppendorf.
Langenbecks Archiv Fur Chirurgie. Supplement II, Verhandlungen Der Deutschen Gesellschaft Fur Chirurgie. Deutsche Gesellschaft Fur Chirurgie. Kongress
|January 1, 1989
Summary
Liver transplants for malignant liver disease have declined due to poor survival rates. Early-stage tumors (T1-3 N0) show better long-term survival than advanced stages (T4 or N1).
Area of Science:
- Hepatology
- Surgical Oncology
- Transplantation Medicine
Context:
- Liver transplantation for malignant liver disease has seen a significant decrease in patient selection, dropping from 40% in 1983 to 23% currently, according to the European Liver Transplant Registry.
- This decline is attributed to suboptimal patient outcomes, with 2-year survival rates around 25-30% for malignant conditions, contrasting sharply with 70% for benign diseases.
Purpose:
- To analyze the prognostic significance of tumor staging in liver transplantation for malignant liver disease.
- To correlate tumor stage (TNM grading) with long-term survival rates in patients undergoing liver transplantation for primary liver cancers.
Summary:
- Recent studies correlating tumor stage and survival indicate that T1-3 and N0 stages are prognostic indicators for long-term survival after liver transplantation.
- Conversely, T4 or N1 stages are associated with a limited prognosis, affecting approximately 90% of patients with hepatocellular carcinoma (HCC) and Klatskin carcinoma within the first postoperative year.
Impact:
- This research highlights the critical role of precise tumor staging in patient selection for liver transplantation, potentially improving resource allocation and patient outcomes.
- Findings may influence clinical decision-making regarding the eligibility of patients with advanced-stage liver cancer for transplantation, emphasizing the need for alternative therapeutic strategies.